Date of Award
6-10-2018
Document Type
Thesis
Publisher
Santa Clara : Santa Clara University, 2018.
Department
Bioengineering
First Advisor
Bill Lu
Abstract
Current cancer therapies leave much to be desired because they are very harmful to the patient and cause a significant decrease in quality of life. Chimeric Antigen Receptors (CAR) are a promising novel approach for treating specific types of leukemia due to their binding affinity for proteins expressed solely on leukemia B cells. This approach increases specificity of how cells receive treatment, thus allowing for the destruction of cancerous cells while leaving the healthy cells unharmed. In this experiment, we show that production of CAR expressing exosomes (liposome like vesicles produced naturally by human cells) is possible through cell transfection. This finding demonstrates that a new wave of cancer therapeutics, that are more specific and have less harmful side effects, are producible.
Recommended Citation
Pierotti, Michael; Piro, Matthew; and Mitchell, Peter, "Production of Living Nanoparticles for Blood Cancer Therapy" (2018). Bioengineering Senior Theses. 80.
https://scholarcommons.scu.edu/bioe_senior/80